UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 738

Sortiert nach

Systemic literature review of the performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: good news of debatable significance

Annals of the rheumatic diseases, 2013-08, Vol.72 (8), p.e21-e21

Zeidler, H

2013

Link zum Volltext

Verfügbarkeit prüfen

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2007-12, Vol.66 (12), p.1560-1567

2007

Link zum Volltext

Verfügbarkeit prüfen

Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

Annals of the rheumatic diseases, 2006-09, Vol.65 (9), p.1175-1183

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

The Lancet (British edition), 2002-04, Vol.359 (9313), p.1187-1193

2002

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the effect of vibrations on the micro-EDM process at the workpiece surface

Precision engineering, 2011-04, Vol.35 (2), p.364-368

2011

Link zum Volltext

Verfügbarkeit prüfen

Post-COVID‑19-Arthritis. Manifestation unter dem klinischen Bild einer reaktiven Arthritis

Zeitschrift für Rheumatologie, 2021-01, Vol.80 (6), p.555-558

Zeidler, H.

2021

Link zum Volltext

Verfügbarkeit prüfen

Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Annals of the rheumatic diseases, 2008-03, Vol.67 (3), p.340-345

2008

Link zum Volltext

Verfügbarkeit prüfen

Persistent clinical efficacy and safety of anti-tumour necrosis factor therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Annals of the rheumatic diseases, 2008-03, Vol.67 (3), p.340-345

2008

Link zum Volltext

Verfügbarkeit prüfen

Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years

Rheumatology (Oxford, England), 2005-05, Vol.44 (5), p.670-676

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

Annals of the rheumatic diseases, 2006-09, Vol.65 (9), p.1147-1153

2006

Link zum Volltext

Verfügbarkeit prüfen

Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries

Annals of the rheumatic diseases, 2004-04, Vol.63 (4), p.342-347

2004

Link zum Volltext

Verfügbarkeit prüfen

Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.229-234

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany

Rheumatology (Oxford, England), 2008-10, Vol.47 (10), p.1527-1534

2008

Link zum Volltext

Verfügbarkeit prüfen

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis : randomised double-blind comparison

The Lancet (British edition), 1999-12, Vol.354 (9196), p.2106-2111

1999

Link zum Volltext

Verfügbarkeit prüfen

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

Annals of the rheumatic diseases, 2001-03, Vol.60 (3), p.199-206

2001

Link zum Volltext

Verfügbarkeit prüfen

Optimized testing for C. trachomatis DNA in synovial fluid samples in clinical practice

Zeitschrift für Rheumatologie, 2015-11, Vol.74 (9), p.824-828

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Annals of the rheumatic diseases, 2003-12, Vol.62 (12), p.1168-1177

2003

Link zum Volltext

Verfügbarkeit prüfen

Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

Rheumatology (Oxford, England), 1999-09, Vol.38 (9), p.878-882

1999

Link zum Volltext

Verfügbarkeit prüfen

A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose Prednisolone Trial

Clinical and experimental rheumatology, 2011-09, Vol.29 (5 Suppl 68), p.S68

2011

Link zum Volltext

Verfügbarkeit prüfen

Micro-EDM Milling of Electrically Nonconducting Zirconia Ceramics

Procedia CIRP, 2013, Vol.6, p.297-302

2013

Link zum Volltext

Verfügbarkeit prüfen

OP0097 Cigarette smoking predicts radiographic progression in the spine in patients with axial spondyloarthritis in a dose-dependent manner

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.85-86

2013

Link zum Volltext

Verfügbarkeit prüfen

OP0247 Reduction of radiographic spinal progression in patients with ankylosing spondylitis treated with non-steroidal anti-inflammatory drugs is most evident in the presence of syndesmophytes and active systemic inflammation

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.139-139

2013

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

Annals of the rheumatic diseases, 1999-04, Vol.58 (4), p.220-225

1999

Link zum Volltext

Verfügbarkeit prüfen

Bacterial triggers and autoimmune rheumatic diseases

Clinical and experimental rheumatology, 2008-01, Vol.26 (1 Suppl 48), p.S12

2008

Link zum Volltext

Verfügbarkeit prüfen

Persistence of Chlamydia trachomatis Is Induced by Ciprofloxacin and Ofloxacin In Vitro

Antimicrobial Agents and Chemotherapy, 2000-12, Vol.44 (12), p.3288-3297

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 738

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(599)
Mit Volltextzugriff
(637)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(453)
Life Sciences & Biomedicine
(325)
Humans
(293)
Biological And Medical Sciences
(179)
Male
(152)
Female
(149)
Medical Sciences
(149)
Rheumatology
(134)
Adult
(119)
Middle Aged
(115)
Physical Sciences
(83)
Technology
(70)
Diseases Of The Osteoarticular System
(67)
Aged
(65)
Animals
(64)
Inflammatory Joint Diseases
(58)
Physics
(56)
Pharmacology. Drug Treatments
(42)
Rheumatoid Arthritis
(42)
Exact Sciences And Technology
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systemic literature review of the performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: good news of debatable significance

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Analysis of the effect of vibrations on the micro-EDM process at the workpiece surface

Post-COVID‑19-Arthritis. Manifestation unter dem klinischen Bild einer reaktiven Arthritis

Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Persistent clinical efficacy and safety of anti-tumour necrosis factor therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries

Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis

Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis : randomised double-blind comparison

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

Optimized testing for C. trachomatis DNA in synovial fluid samples in clinical practice

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose Prednisolone Trial

Micro-EDM Milling of Electrically Nonconducting Zirconia Ceramics

OP0097 Cigarette smoking predicts radiographic progression in the spine in patients with axial spondyloarthritis in a dose-dependent manner

OP0247 Reduction of radiographic spinal progression in patients with ankylosing spondylitis treated with non-steroidal anti-inflammatory drugs is most evident in the presence of syndesmophytes and active systemic inflammation

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

Bacterial triggers and autoimmune rheumatic diseases

Persistence of Chlamydia trachomatis Is Induced by Ciprofloxacin and Ofloxacin In Vitro

Aktive Filter

Suchergebnisse filtern